pharma · Diabetes Mellitus, Type 2 · Sickle Cell Disease · CYCN
Cyclerion Therapeutics
Cyclerion Therapeutics clinical programs — 9 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Gainesville, USA
- Founded
- 1990
- Employees
- 14
- Programs
- 9
- Drugs
- 2
- Patents
- 17
Cyclerion Therapeutics projects
9 ClinicalTrials.gov programs sponsored by Cyclerion Therapeutics.
Cyclerion Therapeutics has 9 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
IW-1701
Cyclerion Therapeutics
Sickle Cell Disease
1 trial -
IW-1973
Cyclerion Therapeutics
Diabetes Mellitus, Type 2
1 trial -
Matching Placebo
Cyclerion Therapeutics
Diabetes Mellitus, Type 2
1 trial -
Olinciguat
Cyclerion Therapeutics
Achalasia
1 trial -
IW-1701
Cyclerion Therapeutics
Healthy
2 trials -
IW-1973
Cyclerion Therapeutics
Healthy
2 trials -
Olinciguat
Cyclerion Therapeutics
Healthy
1 trial -
[14C]-olinciguat
Cyclerion Therapeutics
Healthy Volunteers
1 trial -
[14C]-praliciguat
Cyclerion Therapeutics
Healthy Volunteers
1 trial
Frequently asked questions
How many clinical projects does Cyclerion Therapeutics have?
9 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.